Introduction
As an uncommon anatomical type, brainstem arteriovenous malformations (AVMs) represent 2%-6% of all brain AVMs and about a quarter of AVMs in the posterior cranial fossa. [1] [2] [3] Approximately 80%-90% of patients with brainstem AVMs present with intracranial hemorrhage (ICH). [4] [5] [6] Owing to the proximity to highly eloquent nerves and structures, hemorrhages from brainstem AVMs are associated with death in two-thirds of untreated patients. 7, 8 Although traditional treatment approaches to these lesions (including surgery and stereotactic radiosurgery) have been proposed, the best option is still controversial. 9 During the past decade, embolization with ethylene vinyl alcohol copolymer (Onyx, ev3, Irvine, CA, USA) has become an efficient treatment for AVMs in other parts of the brain. 10, 11 However, there have been few case series that have paid special attention to the techniques, outcomes, and complications of endovascular managements with Onyx for brainstem AVMs. We present our experience in the treatment of these lesions.
Materials and methods

Patient characteristics
This study was approved by the ethics committee of our center. All patients gave written informed consent to participate and privacy was strictly protected. Between 2007 and 2016, approximately 1180 patients with AVMs were recruited in our center. Thirteen patients were diagnosed as brainstem AVMs and received endovascular therapy with Onyx. Diagnoses were mainly confirmed after magnetic resonance angiography (MRA) and digital subtraction angiography (DSA) of all cerebral vessels. Retrospective examinations of patient demographics, clinical presentation, angiographic features, treatment modalities, postoperative complications and outcomes were carried out.
Endovascular procedures
All treatment procedures were performed by transarterial embolization using Onyx with the patients under general anesthesia and continuous electrophysiological monitoring. During the procedure, an intravenous bolus of heparin was administered using 3000 IU, and then 1000 IU per hour.
At the beginning of each procedure, a 5F guiding catheter for pediatric patients or a 6F guiding catheter for adult patients was used to obtain appropriate vascular access. Following the previous diagnostic angiogram, an optimized operating angle or roadmap was prepared for achieving the satisfactory navigation of a selected feeding artery. Then, a Marathon microcatheter aided by a microguidewire (Mirage 008, ev3 or Traxcess-14, Microvention) was coaxially navigated through the guiding catheter into the selected feeding artery and was moved toward the nidus of the AVM. After placement of the microcatheter, a superselective angiogram analysis was performed to identify the safe embolization position; dimethyl sulfoxide (DMSO) was then was injected in a standard manner into the microcatheter as the potent organic solvent. Under constant fluoroscopic visualization, Onyx (mainly 18 and 34) was slowly infused into the nidus of the AVM. Onyx-18 was commonly used for distal penetration into the nidus, and Onyx-34 was suitable particularly for AVMs with high vascular flow. During the process of injection, the direction of Onyx penetration, occlusion of intranidal aneurysms and vein drainage were noted to protect the normal perforating branches and draining veins. Once the consistent reflux of Onyx or unsatisfactory penetration in the nidus was noted, the Marathon microcatheter was pulled out gently from the superselective feeding artery. Then, operators used a new Marathon microcatheter for navigating into another selected feeding artery and repeated the embolization procedures above. The degree of AVM nidus occlusion was evaluated by using a control angiogram technique at the end of endovascular treatment.
As an assistant treatment method, gamma knife radiosurgery (GKS) was performed after incomplete endovascular obliteration.
Clinical follow-up
Clinical follow-up was supplemented by telephone or outpatient interview in treated cases. Angiographic follow-up was performed by using DSA preferably, and MRA was regarded as an alternative in cases when DSA was not available. We identified the treatment as curative until complete AVM nidus occlusion, which was confirmed by angiographic follow-up. Modified Rankin scores (mRS) 2 were considered to be good clinical outcomes.
Results
Characteristics and treatment
These patients included eight males (61.5%) and five females (38.5%) and the mean age was 29.9 years old (range 12-61 years). Twelve patients (92.3%) presented with ICH that was confirmed by computed tomography (CT) and one patient (7.1%) had paroxysmal headache at the time of diagnosis. The malformations were in the midbrain in 10 patients (76.9%, one anterior and nine posterior or dorsal), in the posterior pons in two (15.4%) and pontomedullary in one (7.7%). Demographics and angiographic characteristics of the 13 patients are summarized in Table 1 . The average maximum diameter of the AVM nidi was 30.3 mm (range 10 mm to 70 mm). Fourteen embolization sessions were performed on these 13 patients with one patient having two sessions.
The AVM located at the anterior midbrain surface between the cerebral peduncles was supplied by posterior thalamo-perforating arteries from the bilateral P1 segment of the posterior cerebral arteries (PCAs), bilateral posterior communication arteries and anterior choroidal arteries, and was drained by the basal vein of Rosenthal. The patient had a partial obliteration of the AVM nidus with Onyx injection via unilateral feeding branches of the posterior communication artery and PCA.
For the nine posterior or dorsal midbrain AVMs, the nidus was located at the quadrigeminal plate, below the pineal gland and above the superior cerebellar peduncles. All of these nidi were fed by unilateral or bilateral long circumflex perforators from the PCA, as well as perforators from the S3 segment of the superior cerebellar artery (SCA), and were drained by the basal vein of Rosenthal or directly into the vein of Galen. The posterior or dorsal midbrain AVMs were embolized through the branches of the PCA or SCA. Complete embolization was obtained in two patients and the other seven patients were near-completely or partially occluded ( Figure 1 ).
The AVMs that were located at the posterior pons were commonly supplied by perforating arteries from the basilar trunk, SCA and anterior inferior cerebellar artery (AICA). The drainage vein was the superior petrosal vein. One case received a single injection with Onyx that was sufficient to occlude the nidus completely through the perforating artery from the basilar artery trunk ( Figure 2 ). The other case was obliterated with Onyx via unilateral feeding branches from the S1 segment of SCA, and partial occlusion was achieved by the consistent reflux.
The anterior medullary AVM was located at the posteroinferior of the right vertebrobasilar junction and was fed by branches of the right vertebral artery (VA) at the level of the anterior spinal artery origins. It was drained by the anterior medullary vein. Embolization was performed through the feeding branch of the right vertebral artery and the nidus was partially occluded.
AVM associated aneurysms were identified in three patients, including intranidal aneurysms in two patients and feeding artery aneurysm in one. Although these AVM nidi had incomplete obliteration, all of the coexisting aneurysms were completely occluded with Onyx injection. After incomplete embolization, a total of six patients underwent gamma knife radiosurgery.
Complications and clinical follow-up
Two patients died of acute brainstem infarctions (one posterior midbrain and one ventral medullary) during the perioperative period. Both of them were detected to have vessel occlusion caused by excessive reflux of Onyx. In addition, because of the difficulty of retrieving the distal part of the Marathon microcatheter that was entrapped after injecting Onyx into the tortuous feeding artery, retention of the microcatheter occurred in the case with anterior medullary AVM. Three patients experienced a decline in their overall functional status: One patient suffered a ventral mesencephalic infarction from perforating arteries occlusion that left him hemiplegic and with paralysis of the oculomotor nerve; two patients with pontine AVMs developed hemiplegia and ataxia that were caused by the lesions of pons tegmentum. One patient encountered a postoperative hemorrhagic complication that was caused by near-complete obliteration of the AVM nidus and stenosis of the draining vein. Two patients experienced transient post-procedural diplopia that was restored to normal in a few days. No other complications of treatment were detected. Clinical follow-up was obtained in 10 patients at a mean period of 45.2 months (range 3 to 93 months). Three patients received angiography follow-up that confirmed the durable obliteration or decreased volume of the residual nidus of the AVMs. Angiographic cures were confirmed by DSA. During the follow-up, one patient died of fatal intracranial hemorrhage that was caused by the rupture of residual nidus of posterior pontine AVM. The conditions of the remaining nine patients were unchanged or improved, and seven patients had good clinical outcomes according to their mRS scores. All of the relatively good clinical outcomes were observed in patients with posterior or dorsal midbrain AVM. Table 2 showed the treatment characteristics, complications and follow-up results.
Discussion
Aggressive microsurgical resection for brainstem AVM is not ideal unless the patient is associated with compressing hematoma or critically high risk of death requiring immediate obliteration. 9, 12, 13 Stereotactic radiosurgery has been widely used as a single-modality treatment for AVMs, especially those in the critical area of the brain. 14 However, radiosurgery for brainstem AVMs may cause serious neurological deterioration and has a significant lower obliteration rate than AVMs in other locations. [15] [16] [17] Because the AVM nidus could not be obliterated completely immediately by radiosurgery, post-treatment hemorrhage that is associated with a high mortality rate remains a significant problem of this technique. 18 Endovascular embolization is an alternative that could occlude the nidus of AVMs to decrease the risk of hemorrhage. A previous study reported by Liu et al. indicated that embolization was a curable technique for brainstem AVMs. 1 As a new embolic material, Onyx has been developed and considered as the primary choice for AVMs and intracranial dural arteriovenous fistula (dAVF) embolization because of better control of the embolic agent during injection, injection time, relative higher occlusion rate and lower complication rate. [19] [20] [21] Studies related to the use of Onyx for treatment of brainstem AVM have been reported sporadically. 22 In our case series, the posterior or dorsal midbrain AVMs were the most common subtypes and had relatively good endovascular treatment results. Because of the critical location with lower cranial nerves where the slight reflux of Onyx was not tolerated, embolization with Onyx for the pontine and medullary AVM might result in severe postoperative complications. It was important for operators to choose an optimal feeding artery that was not tortuous or relatively thick for injection during the endovascular procedure. Additionally, reflux of Onyx into feeding arteries of brainstem AVMs could be associated with an unexpected poor prognosis. [21] [22] [23] In our study, five of six patients who suffered severe postoperative complications were detected with reflux of Onyx that might be caused by aggressive attempt or rapid injection. Controlled and slow injection of Onyx had a higher potential capability of penetrating across the arterioles and inhibiting reflux. In addition, navigation of the microcatheter as close as possible to the nidus of the brainstem AVM was critical through an appropriate route because only security catheterization could ensure the safety of diffusion of Onyx. Moreover, the cytotoxic effect of Onyx associated with DMSO should be considered. 24 Cortical brain AVM after Onyx treatment shows that seizure is not uncommon, and newonset seizures may result from Onyx and DMSO administration. 25 As there is a homologous relationship between the brainstem and spinal cord, the angioarchitecture of brainstem AVMs are similar to the perimedullary AVMs at the level of the spinal cord, which is more sensitive to DMSO damage. The development of edema and inflammation surrounding the nidus following Onyx administration may play a role. 26 Complete obliteration for brainstem AVM was commonly difficult to achieve because of multiple feeders and extensions to crucial anatomic structures. 27, 28 Residual nidus obliterated incompletely with Onyx was still accompanied with the potential risk of delayed rupture. 29 Targeted embolization, which could decrease the AVM nidus and deal with the most dangerous factors in AVM structure (such as associated aneurysms), was a recommended therapeutic strategy. Embolization alone was considered to be insufficient to completely eliminate the risk of delayed hemorrhage. Radiosurgery might be a supplementary method for embolization. 3 Six of nine patients in our center received gamma knife radiosurgery after the Onyx injection and four had good clinical outcomes during the follow-up. Brainstem AVMs represent a specific subgroup of deep AVMs that are still a source of concern and require individualized treatment decisions. 6 
Conclusion
Endovascular embolization for brainstem AVMs with Onyx is a technical challenge, and the reflux of Onyx may cause severe complications. Individualized treatment is needed based on the specific subtypes of brainstem AVMs.
